Dr. Shallcross’ research focuses on developing, adapting and testing mindfulness-based interventions for people with depression and co-morbid illness, with an emphasis on scalability, accessibility and health equity. She also has expertise in eating behavior and Food is Medicine interventions. Her work has been funded by the National Institutes of Health, the American Heart Association and the Mind and Life Institute.
Dr. Amanda J. Shallcross is the Vice Chair of Research in the Department and Preventive Medicine at Cleveland Clinic and founding Director of the Center for Wellness Research and Training. She is a behavioral scientist and board-certified naturopathic physician. Dr. Shallcross’ research combines her expertise in clinical trials, emotion regulation, psychophysiology, mind-body treatment approaches, behavior change and population health. Dr. Shallcross has maintained nearly continuous funding from NIH for the last 17 years, including F32 and K23 grants, as well as two R-level grants. She supervises three Assistant Professor-level investigators and has supervised over 50 undergraduate and post-graduate research assistants, medical students and postdoctoral fellows over the past 15 years, including 3 K-grant awardees.
Education
Graduate School – University of Colorado Denver
Public Health
Denver, CO USA
2012
Graduate School – National University of Natural Medicine
Naturopathic Medicine/Naturopathy
Portland, OR USA
2005
Undergraduate – University of Colorado Denver
Biology
Whittier, CA USA
2000
Awards and Honors
Professional Highlights
Memberships
We are conducting a three-arm (1:1:1), RCT pilot trial (n=144) of abbreviated Mindfulness-Based Cognitive Therapy (MBCT-Brief) delivered via telephone or video, compared to enhanced usual care.
We are evaluating the feasibility and acceptability of all three arms in people with migraine (defined by the International Classification of Headache Disorders - 3) and depressive symptoms (defined by empirical cut-offs on the Patient Health Questionnaire - 9).
This study aims to set the stage for a future definitive, large-scale Phase III trial in patients with migraine and depressive symptoms.
This study is a three-arm, RCT pilot trial (n=75) to compare medically tailored meals (MTM) vs. MTM + SMA (shared medical appointments) vs. a wait-list control group (MTM-Later) in patients with hypertension, type 2 diabetes, obesity and/or metabolic syndrome.
Primary outcomes are implementation (recruitment and retention rates) and feasibility (engagement and satisfaction).
Participants are recruited from Cleveland Clinic's South Pointe Hospital in Warrensville Heights, a predominantly Black community with low socioeconomic status and high cardiovascular disease morbidity.
We will investigate the association between ultra-processed food intake and cognitive impairment in at-risk participants.
We will assess potential sex differences in this relationship and evaluate the feasibility and acceptability of digital nutrition tracking tools and education methods in this population.